6533b857fe1ef96bd12b4585

RESEARCH PRODUCT

Viral hepatitis in 2021: The challenges remaining and how we should tackle them

Rebecca DunnAaron WettenStuart McphersonMhairi C Donnelly

subject

Hepatitis Viral HumanGastroenterologyCOVID-19ReviewGeneral MedicineHepatitis AHepatitis BGlobal HealthWorld Health OrganizationHepatitis CAntiviral AgentsHepatitis DHepatitis EHumansMass Screening

description

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO) set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain. These include inequalities in access to healthcare, reaching at risk populations and providing access to screening and effective treatment. Stigma around viral hepatitis persists and must be addressed. The WHO goal of global elimination by 2030 is a worthy aim, but remains ambitious and the coronavirus 2019 pandemic undoubtedly has set back progress. This review article will focus on hepatitis A to E, highlighting problems that have been resolved in the field over the past decade, those that remain to be resolved and suggest directions for future problem solving and research.

https://doi.org/10.3748/wjg.v28.i1.76